Characterization of B.cenocepacia BCAM0223 Mutant 61. Attia AS, Ram S, Rice PA, Hansen EJ (2006) Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun 74: 1597–1611. 62. Estrela A, Heck M, Abraham W (2009) Novel approaches to control biofilm infections. Curr Med Chem 16: 1512–1530. 63. Nordstro¨ m T, Blom AM, Forsgren A, Riesbeck K (2004) The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol 173: 4598– 606. 64. Biedzka-Sarek M, Jarva H, Hyytia¨inen H, Meri S, Skurnik M (2008) Characterization of complement factor H binding to Yersinia enterocolitica serotype O: 3. Infect Immun 76: 4100–9. 65. Leo JC, Lyskowski A, Hattula K, Hartmann MD, Schwarz H, et al. (2011) The structure of E. coli IgG-binding protein D suggests a general model for bending and binding in trimeric autotransporter adhesins. Structure 19: 1021–1030. 66. Ortega X, Hunt TA, Loutet S, Vinion-Dubiel AD, Datta A, et al. (2005) Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis. J Bacteriol 187: 1324–1333. PLoS ONE | www.plosone.org 12 July 2012 | Volume 7 | Issue 7 | e41747